Alpers–Huttenlocher syndrome: the role of a multidisciplinary health care team

Russell P Saneto1,2 1Department of Neurology, University of Washington, 2Division of Pediatric Neurology, Seattle Children’s Hospital, Seattle, WA, USA Abstract: Alpers–Huttenlocher syndrome (AHS) is a mitochondrial DNA-depletion syndrome. Age of onset is bimodal: early onset at...

Full description

Bibliographic Details
Main Author: Saneto RP
Format: Article
Language:English
Published: Dove Medical Press 2016-07-01
Series:Journal of Multidisciplinary Healthcare
Subjects:
Online Access:https://www.dovepress.com/alpersndashhuttenlocher-syndrome-the-role-of-a-multidisciplinary-healt-peer-reviewed-article-JMDH
_version_ 1828909098483056640
author Saneto RP
author_facet Saneto RP
author_sort Saneto RP
collection DOAJ
description Russell P Saneto1,2 1Department of Neurology, University of Washington, 2Division of Pediatric Neurology, Seattle Children’s Hospital, Seattle, WA, USA Abstract: Alpers–Huttenlocher syndrome (AHS) is a mitochondrial DNA-depletion syndrome. Age of onset is bimodal: early onset at 2–4 years and later adolescent onset at 17–24 years of age. Early development is usually normal, with epilepsy heralding the disorder in ~50% of patients. The onset of seizures is coupled with progressive cognitive decline. Hepatopathy is variable, and when present is a progressive dysfunction leading to liver failure in many cases. These features of seizures, cognitive degeneration, and hepatopathy represent the “classic triad” of AHS. However, most patients develop other system involvement. Therefore, although AHS is ultimately a lethal disorder, medical care is required for sustained quality of life. Frequently, additional organ systems – gastrointestinal, respiratory, nutritional, and psychiatric – abnormalities appear and need treatment. Rarely, cardiovascular dysfunction and even pregnancy complicate medical treatment. Optimal care requires a team of physicians and caretakers to make sure quality of life is optimized. The care team, together with the family and palliative care specialists, need to be in communication as the disease progresses and medical changes occur. Although the unpredictable losses of function challenge medical care, the team approach can foster the individual quality-of-life care needed for the patient and family. Keywords: Mitochondrial depletion syndrome, polymerase gamma 1, clinical care, mitochondria
first_indexed 2024-12-13T18:20:33Z
format Article
id doaj.art-1a2378b493564ee982c1a6f494e042cb
institution Directory Open Access Journal
issn 1178-2390
language English
last_indexed 2024-12-13T18:20:33Z
publishDate 2016-07-01
publisher Dove Medical Press
record_format Article
series Journal of Multidisciplinary Healthcare
spelling doaj.art-1a2378b493564ee982c1a6f494e042cb2022-12-21T23:35:43ZengDove Medical PressJournal of Multidisciplinary Healthcare1178-23902016-07-012016Issue 132333328074Alpers–Huttenlocher syndrome: the role of a multidisciplinary health care teamSaneto RPRussell P Saneto1,2 1Department of Neurology, University of Washington, 2Division of Pediatric Neurology, Seattle Children’s Hospital, Seattle, WA, USA Abstract: Alpers–Huttenlocher syndrome (AHS) is a mitochondrial DNA-depletion syndrome. Age of onset is bimodal: early onset at 2–4 years and later adolescent onset at 17–24 years of age. Early development is usually normal, with epilepsy heralding the disorder in ~50% of patients. The onset of seizures is coupled with progressive cognitive decline. Hepatopathy is variable, and when present is a progressive dysfunction leading to liver failure in many cases. These features of seizures, cognitive degeneration, and hepatopathy represent the “classic triad” of AHS. However, most patients develop other system involvement. Therefore, although AHS is ultimately a lethal disorder, medical care is required for sustained quality of life. Frequently, additional organ systems – gastrointestinal, respiratory, nutritional, and psychiatric – abnormalities appear and need treatment. Rarely, cardiovascular dysfunction and even pregnancy complicate medical treatment. Optimal care requires a team of physicians and caretakers to make sure quality of life is optimized. The care team, together with the family and palliative care specialists, need to be in communication as the disease progresses and medical changes occur. Although the unpredictable losses of function challenge medical care, the team approach can foster the individual quality-of-life care needed for the patient and family. Keywords: Mitochondrial depletion syndrome, polymerase gamma 1, clinical care, mitochondriahttps://www.dovepress.com/alpersndashhuttenlocher-syndrome-the-role-of-a-multidisciplinary-healt-peer-reviewed-article-JMDHAlpers-Huttenlocher syndromemitochondrial depletion syndromepolymerase gamma 1multidisciplinary caremitochondrial DNA
spellingShingle Saneto RP
Alpers–Huttenlocher syndrome: the role of a multidisciplinary health care team
Journal of Multidisciplinary Healthcare
Alpers-Huttenlocher syndrome
mitochondrial depletion syndrome
polymerase gamma 1
multidisciplinary care
mitochondrial DNA
title Alpers–Huttenlocher syndrome: the role of a multidisciplinary health care team
title_full Alpers–Huttenlocher syndrome: the role of a multidisciplinary health care team
title_fullStr Alpers–Huttenlocher syndrome: the role of a multidisciplinary health care team
title_full_unstemmed Alpers–Huttenlocher syndrome: the role of a multidisciplinary health care team
title_short Alpers–Huttenlocher syndrome: the role of a multidisciplinary health care team
title_sort alpers ndash huttenlocher syndrome the role of a multidisciplinary health care team
topic Alpers-Huttenlocher syndrome
mitochondrial depletion syndrome
polymerase gamma 1
multidisciplinary care
mitochondrial DNA
url https://www.dovepress.com/alpersndashhuttenlocher-syndrome-the-role-of-a-multidisciplinary-healt-peer-reviewed-article-JMDH
work_keys_str_mv AT sanetorp alpersndashhuttenlochersyndrometheroleofamultidisciplinaryhealthcareteam